Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

PRP treatment helps reduce hair loss in post-COVID-19 patients.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

AA-PRP injections significantly promote hair growth but need better study design for clear efficacy.

Injecting CD34+ cell-containing platelet-rich plasma can improve pattern hair loss more than placental extract treatment.

The treatment promoted hair growth safely and effectively.

The herbal drug worked faster than Minoxidil for treating telogen effluvium.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

The nanohybrid system significantly improved wound healing and showed strong antibacterial activity.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

A new model helps study acne and test treatments.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Biliverdin IXβ and IXδ help Pseudomonas aeruginosa adapt to chronic infections.

A new lab-grown lung model helps study adenoviruses and test antiviral drugs.

Long COVID symptoms vary and are influenced by personal and health factors.

Injecting cosyntropin into grizzly bears increases blood cortisol but doesn't change hair cortisol levels.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

77% of recovered COVID-19 patients in Nepal experienced long-term symptoms like fatigue, hair loss, and breathing issues.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.